Skip to main content

Journals in Medicine

The Medicine portfolio strives to advance medicine by delivering superior evidence-based education, reference information and decision support tools to clinicians, trainees, and students. Specialties covered include Anesthesiology, Internal Medicine, Surgery, Radiology & Imaging, Pathology, Orthopedics, Ophthalmology, Infectious Disease, Allergy & Immunology, Pediatrics, Obstetrics & Gynecology, Hematology & Oncology, Plastic Surgery, and many more. The Medicine portfolio includes world-renowned titles such as Gray's Anatomy and Netter Atlas of Human Anatomy, Braunwald's Heart Disease, Goldman-Cecil Medicine, Osborn's Brain, Dermatology (Bolognia), Diagnostic Ultrasound (Rumack), The Harriet Lane Handbook, Fanaroff and Martin's Neonatal-Perinatal Medicine, Ferri's Clinical Advisor, Conn's Current Therapy, and more.

    • EXPLORE

      • ISSN: 1550-8307
      The Journal of Science & HealingEXPLORE: The Journal of Science & Healing addresses the scientific principles behind, and applications of, evidence-based healing practices from a wide variety of sources, including conventional, alternative, and cross-cultural medicine. It is an interdisciplinary journal that explores the healing arts, consciousness, spirituality, eco-environmental issues, and basic science as all these fields relate to health.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.else...
    • Value in Health

      • ISSN: 1098-3015
      AimsValue in Health aims to be a leading source of new methods, best practice guidelines, and innovative research in the field of health economics and outcomes research (HEOR).Value in Health aims to publish papers that expand the frontiers of HEOR science and have a direct impact on the methods used in HEOR and the evidence on value used in healthcare decision making around the world.Scope Value in Health publishes a wide range of article types that contribute to our aims, including:Original theoretical, conceptual and empirical research in HEOR. Our principal interest is in research that contributes to and extends the way value in healthcare is defined and measured, including (but not limited to):methods for the economic evaluation of drugs and other healthcare technologies; outcomes research to strengthen the methods and evidence available to reflect patient and societal perspectives on effectiveness and value.Innovative and high-impact applications of HEOR methods with interest and relevance beyond the specific country and disease area.Good Practices Reports: Value in Health publishes ISPOR’s Good Practices Reports that identify best and emerging practices in a wide range of areas within HEOR.Systematic Reviews: The Editors welcome systematic reviews of any aspect of HEOR. These should go beyond describing a given body of work by synthesizing and critically reviewing the literature and drawing out lessons for HEOR methods and practice. These papers should review empirical studies consistent with the methods outlined by the Cochrane Collaboration and PRISMA. Health Policy Analyses: Analysis and commentary on health policy issues with global relevance to the pursuit of a world where healthcare is effective, efficient, and affordable for all.The ISPOR journal portfolio consists of Value in Health and Value in Health Regional Issues. For more information and detailed guidance about the article types and formatting requirements for Value in Health, please consult the journal’s Instructions for Authors.
    • Blood

      • ISSN: 0006-4971
      Blood, the flagship journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well-organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to submit a presubmission inquiry if they are uncertain whether their work falls within the general scope of the journal.Blood has formulated more precise scopes for immunobiology and immunotherapy, vascular biology, HIV/HTLV, and clinical trial submissions. The journal is very interested in submissions as reflected in the definitions linked below.Immunobiology and Immunotherapy scopeVascular Biology scopeHIV/HTLV scopeClinical Trials scopeBlood welcomes submission of manuscripts reporting on clinical trials whether phase 1, 2, 3 or 4. Reports should include a full description of the study design, patient population, methodology and conduct, and statistical plan.Immunobiology and Immunotherapy encompass a wide spectrum of research, but Blood can accommodate only papers that have clear and important implications for hematology. Preference is given to papers focusing on human immunobiology, immunotherapy, and immune pharmacology approaches in the human setting and those with significant implications for understanding of normal or malignant hematologic processes. Papers on tumor immunology, tumor vaccines and cancer immunotherapy development may be appropriate if the target cells or antigens are relevant to hematologic malignancies, but generally Blood cannot accommodate tumor immunology papers focusing solely on non-hematologic tumor types.Papers investigating autoimmunity and utilizing non-hematologic models are not within the scope of Blood.Vascular biology papers that focus primarily on atherosclerosis are outside the scope of Blood and instead should be considered for alternative journals.Papers felt to be outside the scope of Blood will be returned to the author without full peer review.